While some wearables may be tailor made for trial use, they face challenges translating to real-world patient applications outside of a stringent trial setting, and vice versa. This creates a unique ...
TaxRock details how its AI tax compliance platform reduces reliance on reactive IRS monitoring for accounting firms, ...
Feb. 4 (UPI) --Officials for Abbott Diabetes Care have recalled some of the company's FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitor sensors for people with diabetes. The Food ...
Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health management, yet most clinical tests rely on invasive, single-point blood ...
Glucose tracking is coming to the Withings app. Withings is one of many tech companies integrating CGM data. Users can begin tracking with an Abbott Lingo CGM in Q1 2026. Companies are integrating ...
The partnership is similar to one between Dexcom and Oura. The partnership is similar to one between Dexcom and Oura. is a senior reporter and author of the Optimizer newsletter. She has more than 13 ...
One of the clearest shifts has been broader adoption of continuous insulation (CI). Rather than relying only on insulation placed between studs, CI places insulation across the exterior of the wall so ...
Hosted on MSN
New Windows 10 update reportedly breaks StartIsBack and causes performance and monitor problems
Windows 10 has a new update as part of Microsoft's extended support It reportedly breaks StartIsBack, a popular customization app The December patch also apparently causes issues with multiple ...
NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, announced the publication of a paper in the journal The Lancet ...
A medical device correction has been initiated for 3 million continuous glucose monitors. Certain Freestyle Libre 3 systems may provide incorrect low glucose readings, which can lead to serious health ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (DXCM) (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results